Details of the Drug Combination

General Information of Drug Combination (ID: DCO2Z1P)

Drug Combination Name

Tolazoline Crotamiton

Indication

Disease Entry	Status	REF
Chronic myelogenous leukemia	Investigative	[1]

Component Drugs

Tolazoline DMI40NL

Crotamiton DM2TUCU

Small molecular drug

2D MOL

3D MOL

High-throughput Screening Result

Testing Cell Line: KBM-7

Zero Interaction Potency (ZIP) Score: 12.23

Bliss Independence Score: 12.23

Loewe Additivity Score: 24.91

LHighest Single Agent (HSA) Score: 24.91

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)

Indication(s) of Tolazoline

Disease Entry	ICD 11	Status	REF
Cerebrovascular disease	8B2Z	Approved	[2]
Pulmonary hypertension	BB01	Approved	[3]
Vascular disease	BE2Z	Investigative	[2]

Tolazoline Interacts with 1 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Dopamine D2 receptor (D2R)	TTEX248	DRD2_HUMAN	Antagonist	[5]
------------------------------------------------------------------------------------

Indication(s) of Crotamiton

Disease Entry	ICD 11	Status	REF
Pruritus	EC90	Approved	[4]

References

1	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
2	Tolazoline FDA Label
3	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7310).
4	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
5	Comparative effects of tolazoline and nitroprusside on human isolated radial artery. Ann Thorac Surg. 2006 Jan;81(1):125-31.